Association between the severity of sepsis and the changes in hemostatic molecular markers and vascular endothelial damage markers

It is well known that disorders of coagulation and fibrinolysis play a major role in the development of organ dysfunction during sepsis. Furthermore, the importance of the early initiation of anticoagulation therapy for severe cases has been emphasized based on the success of recent clinical trials....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Shock (Augusta, Ga.) Ga.), 2005, Vol.23 (1), p.25-29
Hauptverfasser: IBA, Toshiaki, KIDOKORO, Akio, FUKUNAGA, Masaki, SUGIYAMA, Kazuyoshi, SAWADA, Tomohiro, KATO, Hisaaki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 29
container_issue 1
container_start_page 25
container_title Shock (Augusta, Ga.)
container_volume 23
creator IBA, Toshiaki
KIDOKORO, Akio
FUKUNAGA, Masaki
SUGIYAMA, Kazuyoshi
SAWADA, Tomohiro
KATO, Hisaaki
description It is well known that disorders of coagulation and fibrinolysis play a major role in the development of organ dysfunction during sepsis. Furthermore, the importance of the early initiation of anticoagulation therapy for severe cases has been emphasized based on the success of recent clinical trials. The purpose of this study is to search for useful markers for predicting organ dysfunction. Plasma samples were prospectively collected from 78 patients within 48 h after the onset of sepsis. Hemostatic markers and endothelial damage markers were compared between the patients with and without organ dysfunction. The WBC and platelet counts were not different between the groups. In contrast, fibrin/fibrinogen degradation products, D-dimer, thrombin-antithrombin complex, plasmin alpha2-antiplasmin complex, soluble fibrin, and total plasminogen activator inhibitor-1 were significantly higher, and the antithrombin activity and protein C levels were lower in the patients with organ dysfunction. Thus, the changes in the hemostatic molecular markers were associated with organ dysfunction from an early stage of sepsis, and antithrombin and protein C activities were found to be the most reliable markers.
doi_str_mv 10.1097/01.shk.0000144422.32647.b6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67327991</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67327991</sourcerecordid><originalsourceid>FETCH-LOGICAL-c465t-927196c099d3f0d90db900df0cf259d89dc37c35a0ffafeccf160e4c23014cd3</originalsourceid><addsrcrecordid>eNpFkctuHCEQRVEUK3ac_EKEIiW7bhePhpCdZeUlWcrGe0RD4SHubibQY8tbf7mJZ6JhQ4k6tyjdS8hHBj0Doy-A9XVz10M7TErJeS-4krof1StyxgYJHQxMvm41aNFxwfkpeVvrHwAuhdFvyCkbFJOM6zPydFlr9smtKS90xPUBcaHrBmnFeyxpfaQ5tnpbU6VuCS8tv3HLLVaaFrrBOde1qT2d84R-N7lCZ1fusOz5e1f3j7iE3MRTchMNbna3-J97R06imyq-P9zn5Ob7t5urn9317x-_ri6vOy_VsHaGa2aUB2OCiBAMhNEAhAg-8sGELyZ4ob0YHMToInofmQKUnovmkg_inHzej92W_HeHdbVzqh6nyS2Yd9UqLbg2hjXw6x70JddaMNptSW3XR8vA_gvAArMtAHsMwL4EYEfVxB8Ov-zGGcNRenC8AZ8OQHPGTbG4xad65JQwhhshngH7TJM1</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67327991</pqid></control><display><type>article</type><title>Association between the severity of sepsis and the changes in hemostatic molecular markers and vascular endothelial damage markers</title><source>MEDLINE</source><source>Journals@Ovid LWW Legacy Archive</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><creator>IBA, Toshiaki ; KIDOKORO, Akio ; FUKUNAGA, Masaki ; SUGIYAMA, Kazuyoshi ; SAWADA, Tomohiro ; KATO, Hisaaki</creator><creatorcontrib>IBA, Toshiaki ; KIDOKORO, Akio ; FUKUNAGA, Masaki ; SUGIYAMA, Kazuyoshi ; SAWADA, Tomohiro ; KATO, Hisaaki</creatorcontrib><description>It is well known that disorders of coagulation and fibrinolysis play a major role in the development of organ dysfunction during sepsis. Furthermore, the importance of the early initiation of anticoagulation therapy for severe cases has been emphasized based on the success of recent clinical trials. The purpose of this study is to search for useful markers for predicting organ dysfunction. Plasma samples were prospectively collected from 78 patients within 48 h after the onset of sepsis. Hemostatic markers and endothelial damage markers were compared between the patients with and without organ dysfunction. The WBC and platelet counts were not different between the groups. In contrast, fibrin/fibrinogen degradation products, D-dimer, thrombin-antithrombin complex, plasmin alpha2-antiplasmin complex, soluble fibrin, and total plasminogen activator inhibitor-1 were significantly higher, and the antithrombin activity and protein C levels were lower in the patients with organ dysfunction. Thus, the changes in the hemostatic molecular markers were associated with organ dysfunction from an early stage of sepsis, and antithrombin and protein C activities were found to be the most reliable markers.</description><identifier>ISSN: 1073-2322</identifier><identifier>EISSN: 1540-0514</identifier><identifier>DOI: 10.1097/01.shk.0000144422.32647.b6</identifier><identifier>PMID: 15614127</identifier><language>eng</language><publisher>Augusta, GA: BioMedical Press</publisher><subject>Adult ; Aged ; alpha-2-Antiplasmin - biosynthesis ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Antithrombin III ; Antithrombins - biosynthesis ; Area Under Curve ; Biological and medical sciences ; Biomarkers - blood ; Blood Cell Count ; Blood Coagulation Tests ; Blood. Blood coagulation. Reticuloendothelial system ; Emergency and intensive care: infection, septic shock ; Endothelium, Vascular - cytology ; Female ; Fibrin - biosynthesis ; Fibrin Fibrinogen Degradation Products - biosynthesis ; Hemostasis ; Humans ; Intensive care medicine ; Male ; Medical sciences ; Middle Aged ; Peptide Hydrolases - blood ; Pharmacology. Drug treatments ; Plasminogen Activator Inhibitor 1 - blood ; ROC Curve ; Sepsis - blood ; Sepsis - immunology ; Sepsis - pathology ; Time Factors</subject><ispartof>Shock (Augusta, Ga.), 2005, Vol.23 (1), p.25-29</ispartof><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c465t-927196c099d3f0d90db900df0cf259d89dc37c35a0ffafeccf160e4c23014cd3</citedby><cites>FETCH-LOGICAL-c465t-927196c099d3f0d90db900df0cf259d89dc37c35a0ffafeccf160e4c23014cd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16399293$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15614127$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>IBA, Toshiaki</creatorcontrib><creatorcontrib>KIDOKORO, Akio</creatorcontrib><creatorcontrib>FUKUNAGA, Masaki</creatorcontrib><creatorcontrib>SUGIYAMA, Kazuyoshi</creatorcontrib><creatorcontrib>SAWADA, Tomohiro</creatorcontrib><creatorcontrib>KATO, Hisaaki</creatorcontrib><title>Association between the severity of sepsis and the changes in hemostatic molecular markers and vascular endothelial damage markers</title><title>Shock (Augusta, Ga.)</title><addtitle>Shock</addtitle><description>It is well known that disorders of coagulation and fibrinolysis play a major role in the development of organ dysfunction during sepsis. Furthermore, the importance of the early initiation of anticoagulation therapy for severe cases has been emphasized based on the success of recent clinical trials. The purpose of this study is to search for useful markers for predicting organ dysfunction. Plasma samples were prospectively collected from 78 patients within 48 h after the onset of sepsis. Hemostatic markers and endothelial damage markers were compared between the patients with and without organ dysfunction. The WBC and platelet counts were not different between the groups. In contrast, fibrin/fibrinogen degradation products, D-dimer, thrombin-antithrombin complex, plasmin alpha2-antiplasmin complex, soluble fibrin, and total plasminogen activator inhibitor-1 were significantly higher, and the antithrombin activity and protein C levels were lower in the patients with organ dysfunction. Thus, the changes in the hemostatic molecular markers were associated with organ dysfunction from an early stage of sepsis, and antithrombin and protein C activities were found to be the most reliable markers.</description><subject>Adult</subject><subject>Aged</subject><subject>alpha-2-Antiplasmin - biosynthesis</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Antithrombin III</subject><subject>Antithrombins - biosynthesis</subject><subject>Area Under Curve</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>Blood Cell Count</subject><subject>Blood Coagulation Tests</subject><subject>Blood. Blood coagulation. Reticuloendothelial system</subject><subject>Emergency and intensive care: infection, septic shock</subject><subject>Endothelium, Vascular - cytology</subject><subject>Female</subject><subject>Fibrin - biosynthesis</subject><subject>Fibrin Fibrinogen Degradation Products - biosynthesis</subject><subject>Hemostasis</subject><subject>Humans</subject><subject>Intensive care medicine</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Peptide Hydrolases - blood</subject><subject>Pharmacology. Drug treatments</subject><subject>Plasminogen Activator Inhibitor 1 - blood</subject><subject>ROC Curve</subject><subject>Sepsis - blood</subject><subject>Sepsis - immunology</subject><subject>Sepsis - pathology</subject><subject>Time Factors</subject><issn>1073-2322</issn><issn>1540-0514</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkctuHCEQRVEUK3ac_EKEIiW7bhePhpCdZeUlWcrGe0RD4SHubibQY8tbf7mJZ6JhQ4k6tyjdS8hHBj0Doy-A9XVz10M7TErJeS-4krof1StyxgYJHQxMvm41aNFxwfkpeVvrHwAuhdFvyCkbFJOM6zPydFlr9smtKS90xPUBcaHrBmnFeyxpfaQ5tnpbU6VuCS8tv3HLLVaaFrrBOde1qT2d84R-N7lCZ1fusOz5e1f3j7iE3MRTchMNbna3-J97R06imyq-P9zn5Ob7t5urn9317x-_ri6vOy_VsHaGa2aUB2OCiBAMhNEAhAg-8sGELyZ4ob0YHMToInofmQKUnovmkg_inHzej92W_HeHdbVzqh6nyS2Yd9UqLbg2hjXw6x70JddaMNptSW3XR8vA_gvAArMtAHsMwL4EYEfVxB8Ov-zGGcNRenC8AZ8OQHPGTbG4xad65JQwhhshngH7TJM1</recordid><startdate>2005</startdate><enddate>2005</enddate><creator>IBA, Toshiaki</creator><creator>KIDOKORO, Akio</creator><creator>FUKUNAGA, Masaki</creator><creator>SUGIYAMA, Kazuyoshi</creator><creator>SAWADA, Tomohiro</creator><creator>KATO, Hisaaki</creator><general>BioMedical Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2005</creationdate><title>Association between the severity of sepsis and the changes in hemostatic molecular markers and vascular endothelial damage markers</title><author>IBA, Toshiaki ; KIDOKORO, Akio ; FUKUNAGA, Masaki ; SUGIYAMA, Kazuyoshi ; SAWADA, Tomohiro ; KATO, Hisaaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c465t-927196c099d3f0d90db900df0cf259d89dc37c35a0ffafeccf160e4c23014cd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Aged</topic><topic>alpha-2-Antiplasmin - biosynthesis</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Antithrombin III</topic><topic>Antithrombins - biosynthesis</topic><topic>Area Under Curve</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>Blood Cell Count</topic><topic>Blood Coagulation Tests</topic><topic>Blood. Blood coagulation. Reticuloendothelial system</topic><topic>Emergency and intensive care: infection, septic shock</topic><topic>Endothelium, Vascular - cytology</topic><topic>Female</topic><topic>Fibrin - biosynthesis</topic><topic>Fibrin Fibrinogen Degradation Products - biosynthesis</topic><topic>Hemostasis</topic><topic>Humans</topic><topic>Intensive care medicine</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Peptide Hydrolases - blood</topic><topic>Pharmacology. Drug treatments</topic><topic>Plasminogen Activator Inhibitor 1 - blood</topic><topic>ROC Curve</topic><topic>Sepsis - blood</topic><topic>Sepsis - immunology</topic><topic>Sepsis - pathology</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>IBA, Toshiaki</creatorcontrib><creatorcontrib>KIDOKORO, Akio</creatorcontrib><creatorcontrib>FUKUNAGA, Masaki</creatorcontrib><creatorcontrib>SUGIYAMA, Kazuyoshi</creatorcontrib><creatorcontrib>SAWADA, Tomohiro</creatorcontrib><creatorcontrib>KATO, Hisaaki</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Shock (Augusta, Ga.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>IBA, Toshiaki</au><au>KIDOKORO, Akio</au><au>FUKUNAGA, Masaki</au><au>SUGIYAMA, Kazuyoshi</au><au>SAWADA, Tomohiro</au><au>KATO, Hisaaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association between the severity of sepsis and the changes in hemostatic molecular markers and vascular endothelial damage markers</atitle><jtitle>Shock (Augusta, Ga.)</jtitle><addtitle>Shock</addtitle><date>2005</date><risdate>2005</risdate><volume>23</volume><issue>1</issue><spage>25</spage><epage>29</epage><pages>25-29</pages><issn>1073-2322</issn><eissn>1540-0514</eissn><abstract>It is well known that disorders of coagulation and fibrinolysis play a major role in the development of organ dysfunction during sepsis. Furthermore, the importance of the early initiation of anticoagulation therapy for severe cases has been emphasized based on the success of recent clinical trials. The purpose of this study is to search for useful markers for predicting organ dysfunction. Plasma samples were prospectively collected from 78 patients within 48 h after the onset of sepsis. Hemostatic markers and endothelial damage markers were compared between the patients with and without organ dysfunction. The WBC and platelet counts were not different between the groups. In contrast, fibrin/fibrinogen degradation products, D-dimer, thrombin-antithrombin complex, plasmin alpha2-antiplasmin complex, soluble fibrin, and total plasminogen activator inhibitor-1 were significantly higher, and the antithrombin activity and protein C levels were lower in the patients with organ dysfunction. Thus, the changes in the hemostatic molecular markers were associated with organ dysfunction from an early stage of sepsis, and antithrombin and protein C activities were found to be the most reliable markers.</abstract><cop>Augusta, GA</cop><pub>BioMedical Press</pub><pmid>15614127</pmid><doi>10.1097/01.shk.0000144422.32647.b6</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1073-2322
ispartof Shock (Augusta, Ga.), 2005, Vol.23 (1), p.25-29
issn 1073-2322
1540-0514
language eng
recordid cdi_proquest_miscellaneous_67327991
source MEDLINE; Journals@Ovid LWW Legacy Archive; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete
subjects Adult
Aged
alpha-2-Antiplasmin - biosynthesis
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Antithrombin III
Antithrombins - biosynthesis
Area Under Curve
Biological and medical sciences
Biomarkers - blood
Blood Cell Count
Blood Coagulation Tests
Blood. Blood coagulation. Reticuloendothelial system
Emergency and intensive care: infection, septic shock
Endothelium, Vascular - cytology
Female
Fibrin - biosynthesis
Fibrin Fibrinogen Degradation Products - biosynthesis
Hemostasis
Humans
Intensive care medicine
Male
Medical sciences
Middle Aged
Peptide Hydrolases - blood
Pharmacology. Drug treatments
Plasminogen Activator Inhibitor 1 - blood
ROC Curve
Sepsis - blood
Sepsis - immunology
Sepsis - pathology
Time Factors
title Association between the severity of sepsis and the changes in hemostatic molecular markers and vascular endothelial damage markers
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T15%3A56%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20between%20the%20severity%20of%20sepsis%20and%20the%20changes%20in%20hemostatic%20molecular%20markers%20and%20vascular%20endothelial%20damage%20markers&rft.jtitle=Shock%20(Augusta,%20Ga.)&rft.au=IBA,%20Toshiaki&rft.date=2005&rft.volume=23&rft.issue=1&rft.spage=25&rft.epage=29&rft.pages=25-29&rft.issn=1073-2322&rft.eissn=1540-0514&rft_id=info:doi/10.1097/01.shk.0000144422.32647.b6&rft_dat=%3Cproquest_cross%3E67327991%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67327991&rft_id=info:pmid/15614127&rfr_iscdi=true